Aptus Pharma Ltd Q4 FY26 results press release summary

Results press release of 28 Apr 2026, summarised by AI from the filing.

Aptus Pharma FY26 revenue ₹4,670.81 lakh, up 89.59%, PAT ₹461.99 lakh, up 49.05%.

Key takeaways

1. Revenue doubled FY26 total revenue ₹4,670.81 lakh (FY25: ₹2,463.64 lakh, +89.59%).
2. Profit growth FY26 PAT ₹461.99 lakh (FY25: ₹309.96 lakh, +49.05%).
3. Portfolio expansion Product portfolio expanded to 250+ formulations across chronic, acute and wellness segments.
4. Distribution reach Distribution network covers 25K+ retail outlets with 200+ distributors and 10K+ doctors.
5. Long-term roadmap Roadmap to pan-India presence by 2030 and national-level player over the next 3-5 years.

Original filing on BSE

Aptus Pharma Ltd earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (21 Aug 2026)
• Q4 FY26: Results press release (28 Apr 2026)
• Other events: Strategy deck (7 Feb 2026)